BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Med’s Industry

Bayer AG Partners with Thermo Fisher for Breakthrough in Cancer Treatment Diagnostics

Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapie...

March 20, 2024 | News

A New Dawn in Heart Care: Singapore Leads with Innovative CVD Prevention Plan

In an interaction with BioPharma APAC, Dr. Low Lip Ping, Chairman Emeritus of the Singapore Heart Foundation, sheds light on the critical f...

March 20, 2024 | Interaction

Asieris Announces Breakthrough Non-Surgical Treatment for Cervical High-Grade Squamous Intraepithelial Lesion

Asieris Pharmaceuticals (Stock Code: 688176.SH), a trailblazer in the global biopharmaceutical industry with a focus on genitourinary tumors and related di...

March 19, 2024 | News

South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection

Lunit, a trailblazer in AI-driven diagnostics and cancer treatment, announced significant strides in its European market presence through new...

March 19, 2024 | News

Chipscreen Biosciences Announces Successful Phase II Trial of Chiglitazar for NASH Treatment

The CGZ203 study, a randomized, double-blind, placebo-controlled trial conducted across 24 national clinical sites, aimed to assess the saf...

March 19, 2024 | News

EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices

Under the agreement signed on March 13, 2024, in Bellevue, Washington, EDAN and GH Labs will combine their expertise to create innovative ul...

March 18, 2024 | News

Revvity Launches Revolutionary Newborn Sequencing Workflow to Advance Rare Disease Diagnosis

Revvity, Inc., a pioneering force in genomic sequencing technology, has announced the launch of a groundbreaking "sample-to-answer" workflow tailored speci...

March 18, 2024 | News

BeiGene's TEVIMBRA Wins FDA Nod for Advanced Esophageal Cancer Post-Chemotherapy

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has app...

March 15, 2024 | News

X-Therma Raises $22.4 Million in Series B Funding to Revolutionize Regenerative Medicine and Extend Organ Preservation

X-Therma Inc., an innovator in biotechnology focusing on regenerative medicine and organ preservation, announces the successful completion ...

March 14, 2024 | News

Almirall and Eloxx Pharmaceuticals Forge Exclusive Global License Agreement for Rare Disease Treatment ZKN-013

Almirall, S.A. (BME:ALM), a global biopharmaceutical company, and Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a clinical-stage biopharmaceutical innovator, ha...

March 14, 2024 | News

Genesis MedTech and Silk Road Medical Partner to Treat Carotid Artery Disease in China

Since its establishment in 2019, Genesis MedTech Group has continuously strived to enhance its peripheral interventional portfolio, offering compre...

March 11, 2024 | News

Johnson & Johnson Completes $2 Billion Acquisition of Ambrx Biopharma, Bolstering Oncology Pipeline

Johnson & Johnson (NYSE: JNJ) announced it has successfully completed the acquisition of Ambrx Biopharma, Inc., a clinical-stage biopharmaceutica...

March 08, 2024 | News

BioGate Announces Breakthrough in Pancreatic Cancer Treatment with New Drug BGX

Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...

March 07, 2024 | News

Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy

Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...

March 06, 2024 | News

Stay Connected